サマリー

The Business Research Companyの後期慢性腎臓病治療薬の世界市場レポート2023は、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている後期慢性腎臓病治療薬市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。

購入の理由
- 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。
- 市場がコロナウイルスからどのような影響を受けたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。
- ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。
- 世界的な高インフレが市場成長に与える影響を測定する。
- 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。
- 最新の市場シェアに基づいて顧客を理解する。
- 主要な競合他社に対する業績のベンチマーク
- 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。
- レポートの全データは、エクセルのダッシュボード形式でも納品されます。

説明
後期慢性腎臓病治療薬の最大かつ最速の成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後の市場を形成する力は何か？ビジネスリサーチ社の後期慢性腎臓病治療薬世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。

当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。

調査範囲

対象市場：1） 製品タイプ別カルシメティックス；ビタミンD；ステロール；カリウム結合剤；カルシウムベースのリン酸結合剤
2) 適応症タイプ別後期慢性腎臓病による副甲状腺機能亢進症；後期慢性腎臓病による高リン血症；後期慢性腎臓病による高カリウム血症
3) 販売チャネル別病院薬局；オンライン薬局；小売薬局

言及された企業ファイザー；ジョンソン・エンド・ジョンソン；アッヴィ；バイエル；ノバルティス

国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、

データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

納品形式PDF、Word、Excel データダッシュボード。

ページTOPに戻る

目次

1. Executive Summary
2. Late Stage Chronic Kidney Disease Drugs Market Characteristics
3. Late Stage Chronic Kidney Disease Drugs Market Trends And Strategies
4. Late Stage Chronic Kidney Disease Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Late Stage Chronic Kidney Disease Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Late Stage Chronic Kidney Disease Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Late Stage Chronic Kidney Disease Drugs Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Late Stage Chronic Kidney Disease Drugs Market Segmentation
6.1. Global Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Calcimimetics
Vitamin D
Sterols
Potassium Binders
Calcium-Based Phosphate Binders
6.2. Global Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Late Stage Chronic Kidney Disease Induced Hyperparathyroidism
Late Stage Chronic Kidney Disease Induced Hyperphosphatemia
Late Stage Chronic Kidney Disease Induced Hyperkalaemia
6.3. Global Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
7. Late Stage Chronic Kidney Disease Drugs Market Regional And Country Analysis
7.1. Global Late Stage Chronic Kidney Disease Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Late Stage Chronic Kidney Disease Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market
8.1. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Late Stage Chronic Kidney Disease Drugs Market
9.1. China Late Stage Chronic Kidney Disease Drugs Market Overview
9.2. China Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Late Stage Chronic Kidney Disease Drugs Market
10.1. India Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Late Stage Chronic Kidney Disease Drugs Market
11.1. Japan Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Late Stage Chronic Kidney Disease Drugs Market
12.1. Australia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Late Stage Chronic Kidney Disease Drugs Market
13.1. Indonesia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Late Stage Chronic Kidney Disease Drugs Market
14.1. South Korea Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Late Stage Chronic Kidney Disease Drugs Market
15.1. Western Europe Late Stage Chronic Kidney Disease Drugs Market Overview
15.2. Western Europe Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Late Stage Chronic Kidney Disease Drugs Market
16.1. UK Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Late Stage Chronic Kidney Disease Drugs Market
17.1. Germany Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Late Stage Chronic Kidney Disease Drugs Market
18.1. France Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Late Stage Chronic Kidney Disease Drugs Market
19.1. Italy Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Late Stage Chronic Kidney Disease Drugs Market
20.1. Spain Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Late Stage Chronic Kidney Disease Drugs Market
21.1. Eastern Europe Late Stage Chronic Kidney Disease Drugs Market Overview
21.2. Eastern Europe Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Late Stage Chronic Kidney Disease Drugs Market
22.1. Russia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Late Stage Chronic Kidney Disease Drugs Market
23.1. North America Late Stage Chronic Kidney Disease Drugs Market Overview
23.2. North America Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Late Stage Chronic Kidney Disease Drugs Market
24.1. USA Late Stage Chronic Kidney Disease Drugs Market Overview
24.2. USA Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Late Stage Chronic Kidney Disease Drugs Market
25.1. Canada Late Stage Chronic Kidney Disease Drugs Market Overview
25.2. Canada Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Late Stage Chronic Kidney Disease Drugs Market
26.1. South America Late Stage Chronic Kidney Disease Drugs Market Overview
26.2. South America Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Late Stage Chronic Kidney Disease Drugs Market
27.1. Brazil Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Late Stage Chronic Kidney Disease Drugs Market
28.1. Middle East Late Stage Chronic Kidney Disease Drugs Market Overview
28.2. Middle East Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Late Stage Chronic Kidney Disease Drugs Market
29.1. Africa Late Stage Chronic Kidney Disease Drugs Market Overview
29.2. Africa Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Late Stage Chronic Kidney Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Late Stage Chronic Kidney Disease Drugs Market Competitive Landscape And Company Profiles
30.1. Late Stage Chronic Kidney Disease Drugs Market Competitive Landscape
30.2. Late Stage Chronic Kidney Disease Drugs Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AbbVie Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Bayer AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Novartis AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Late Stage Chronic Kidney Disease Drugs Market Other Major And Innovative Companies
31.1. Sanofi SA
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Eli Lilly and Company
31.5. C.H. Boehringer Sohn AG & Co. KG
31.6. Amgen Inc.
31.7. Novo Nordisk A/S
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Otsuka Pharmaceutical Co. Ltd.
31.10. Takeda Pharmaceutical Company Limited
31.11. Kyowa Kirin Co Ltd.
31.12. Vifor Pharma Management Ltd.
31.13. OPKO Health Inc.
31.14. Evotec SE
31.15. Ionis Pharmaceuticals Inc.
32. Global Late Stage Chronic Kidney Disease Drugs Market Competitive Benchmarking
33. Global Late Stage Chronic Kidney Disease Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Late Stage Chronic Kidney Disease Drugs Market
35. Late Stage Chronic Kidney Disease Drugs Market Future Outlook and Potential Analysis
35.1 Late Stage Chronic Kidney Disease Drugs Market In 2027 - Countries Offering Most New Opportunities
35.2 Late Stage Chronic Kidney Disease Drugs Market In 2027 - Segments Offering Most New Opportunities
35.3 Late Stage Chronic Kidney Disease Drugs Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer